Fernando Mateus serves as Executive at ABBOTT LABORATORIES, where they oversee executive responsibilities. Since joining the company, Fernando Mateus has executed 9 insider transactions totaling $267.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 28, 2023 involved selling 1,024 shares valued at $102.2K.
Fernando Mateus currently holds 22,857 shares of ABBOTT LABORATORIES (ABT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fernando Mateus has been a net seller of ABT stock. They have purchased $0 and sold $267.9K worth of shares.
Fernando Mateus's most recent insider trade was on Feb 28, 2023, when they sold 1,024 shares at $99.77 per share.
Get notified when new Form 4 filings are submitted
| $106.74 |
| Discretionary |
| Feb 19, 2023 | ABT | $55.3K | Payment | 518 | $106.74 | Discretionary |
| Feb 17, 2023 | ABT | $0 | Award | 10,560 | $N/A | Discretionary |
| Jul 26, 2022 | ABT | $267.9K | Sale | 2,457 | $109.05 | Discretionary |
| Feb 22, 2022 | ABT | $103.5K | Payment | 886 | $116.79 | Discretionary |
| Feb 21, 2022 | ABT | $81.9K | Payment | 701 | $116.79 | Discretionary |
| Feb 19, 2022 | ABT | $69.5K | Payment | 595 | $116.79 | Discretionary |
| Feb 18, 2022 | ABT | $0 | Award | 10,482 | $N/A | Discretionary |